DeepMed Research

Novo Nordisk A/S

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: Public

Established: 1923-01-01

Employees: 63.3K

Market Cap: $602.2B

Website: http://www.novonordisk.com

Clinical Trials

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets

Phase 1

Completed

Conditions: Healthy Volunteers
Type 2 Diabetes

Interventions: Drug: Oral semaglutide

First Posted Date: 2019-09-20

Last Posted Date: 2022-09-13

Lead Sponsor: Novo Nordisk A/S

Target Recruit Count: 274

Registration Number: NCT04097600

Locations: 🇩🇪
Novo Nordisk Investigational Site, Berlin, Germany

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Semaglutide

First Posted Date: 2019-09-19

Last Posted Date: 2023-02-23

Lead Sponsor: Novo Nordisk A/S

Target Recruit Count: 581

Registration Number: NCT04094415

Locations: 🇮🇹
Novo Nordisk Investigational Site, Vigevano, Italy

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: semaglutide

First Posted Date: 2019-09-10

Last Posted Date: 2023-03-28

Lead Sponsor: Novo Nordisk A/S

Target Recruit Count: 521

Registration Number: NCT04083820

Locations: 🇫🇷
Novo Nordisk Investigational Site, Yerres, France

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors

Phase 3

Active, not recruiting

Conditions: Haemophilia A With Inhibitors
Haemophilia B With Inhibitors

Interventions: Drug: Concizumab

First Posted Date: 2019-09-10

Last Posted Date: 2025-05-21

Lead Sponsor: Novo Nordisk A/S

Target Recruit Count: 134

Registration Number: NCT04083781

Locations: 🇷🇸
University Clinical Centre Kragujevac, Kragujevac, Serbia
🇺🇸
Center for Inherited Blood Dis, Orange, California, United States
🇺🇸
Children's Healthcare Atlanta, Atlanta, Georgia, United States

and more 77 locations

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

Phase 3

Active, not recruiting

Conditions: Haemophilia B Without Inhibitors
Haemophilia A Without Inhibitors

Interventions: Drug: Concizumab

First Posted Date: 2019-09-09

Last Posted Date: 2025-05-21

Lead Sponsor: Novo Nordisk A/S

Target Recruit Count: 158

Registration Number: NCT04082429

Locations: 🇷🇸
University Clinical Centre Kragujevac, Kragujevac, Serbia
🇷🇸
Clinical Centre of Vojvodina, Novi Sad, Serbia
🇷🇸
Institute for Mother and Child Health Care of Serbia, Belgrade, Serbia

and more 78 locations

Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity

Phase 3

Completed

Conditions: Obesity
Overweight

Interventions: Drug: Semaglutide
Drug: Placebo (semaglutide)
Drug: Liraglutide
Drug: Placebo (liraglutide)

First Posted Date: 2019-08-29

Last Posted Date: 2023-05-19

Lead Sponsor: Novo Nordisk A/S

Target Recruit Count: 338

Registration Number: NCT04074161

Locations: 🇺🇸
Novo Nordisk Investigational Site, Olympia, Washington, United States

Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant

Phase 1

Completed

Conditions: Overweight
Obesity

Interventions: Drug: NNC0174-0833
Drug: Oral contraceptive (OC) tablets
Drug: Acetaminophen

First Posted Date: 2019-08-29

Last Posted Date: 2022-01-10

Lead Sponsor: Novo Nordisk A/S

Target Recruit Count: 31

Registration Number: NCT04074174

Locations: 🇨🇦
Novo Nordisk Investigational Site, Montreal, Quebec, Canada

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Semaglutide

First Posted Date: 2019-08-28

Last Posted Date: 2021-09-24

Lead Sponsor: Novo Nordisk A/S

Target Recruit Count: 230

Registration Number: NCT04067999

Locations: 🇪🇸
Novo Nordisk Investigational Site, Álava, Spain

A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels

Phase 1

Completed

Conditions: Healthy Volunteers
Hypercholesterolaemia

Interventions: Drug: NNC0385-0434
Drug: Placebo (NNC0385-0434)

First Posted Date: 2019-08-16

Last Posted Date: 2021-12-30

Lead Sponsor: Novo Nordisk A/S

Target Recruit Count: 39

Registration Number: NCT04058834

Locations: 🇬🇧
Novo Nordisk Investigational Site, Harrow, United Kingdom

Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People

Phase 1

Completed

Conditions: Obesity
Healthy Volunteers
Overweight

Interventions: Drug: NNC9204-1177
Drug: Cocktail of 5 already approved drugs

First Posted Date: 2019-08-16

Last Posted Date: 2020-01-22

Lead Sponsor: Novo Nordisk A/S

Target Recruit Count: 45

Registration Number: NCT04059367

Locations: 🇺🇸
Novo Nordisk Investigational Site, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy